Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome

Gail J. RobozDepartment of Medicine, Weill Medical College of Cornell University, New York, NY, USACorrespondence[email protected]

H. Jean KhouryDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA

Elias JabbourDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Wilena SessionDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA

Ellen K. RitchieDepartment of Medicine, Weill Medical College of Cornell University, New York, NY, USA

Harry MiaoSanofi Oncology, Cambridge, MA, USA

Stefan FaderlDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Wei ZhengSanofi Oncology, Cambridge, MA, USA

Eric J. FeldmanDepartment of Medicine, Weill Medical College of Cornell University, New York, NY, USA

Martha ArellanoDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA

J. Gilmour MorrisonCovance Laboratories, Alnwick, UK

Farhad RavandiDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

show all

References

Burnett A, Wetzler M, Lowenberg B. Therapeutic advances in acute myeloid leukemia. J Clin Oncol 2011;29:487–494.
PubMed Web of Science ®Google Scholar
Roboz GJ. Current treatment of acute myeloid leukemia. Curr Opin Oncol 2012;24:711–719.
PubMed Web of Science ®Google Scholar
Szer J. The prevalent predicament of relapsed acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2012:43–48.
PubMedGoogle Scholar
Giles F, O’Brien S, Cortes J, et al. Outcome of patients with acute myelogenous leukemia after second salvage therapy. Cancer 2005;104:547–554.
PubMed Web of Science ®Google Scholar
Bourrie B, Brassard DL, Cosnier-Pucheu S, et al. SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias. Leuk Lymphoma 2013;54:1488–1499.
PubMed Web of Science ®Google Scholar
Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642–4649.
PubMed Web of Science ®Google Scholar
Guilhot J, Baccarani M, Clark RE, et al. Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet. Blood 2012; 119:5963–5971.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date